Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Medulloblastoma 1Familial ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 10Temozolomide 9X-Rays 7Specimen Handling 7Phantoms, Imaging 7Filgrastim 6Nuclear Medicine Department, Hospital 5Cyclophosphamide 5Carboplatin 5Vorinostat 4Thiotepa 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Irinotecan 4Cisplatin 4Biopsy 4tipifarnib 3O(6)-benzylguanine 3HhAntag691 3veliparib 2ulixertinib 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Vincristine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Medulloblastoma × phenylacetic acid × Clear all
NCT00003241 2013-06-26

Phenylacetate in Treating Children With Recurrent or Progressive Brain Tumors

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Familial ependymoma, Astrocytoma, Medulloblastoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡